Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2020-06-25 2020-03-13
Drug Identification Number 02130955 02130955
Brand name TYPHIM VI TYPHIM VI
Common or Proper name Salmonella typhi Vi Capsular Polysaccharide Vaccine Salmonella typhi Vi Capsular Polysaccharide Vaccine
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Strength(s) 25MCG 25MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL (single dose) syringe 1 x 0.5 mL (single dose) syringe
ATC code J07AP J07AP
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-03-11 2020-03-11
Actual start date 2020-03-11 2020-03-11
Estimated end date 2020-07-31 2020-07-31
Actual end date 2020-06-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments (Shortage resolved as of June 24, 2020) PFS presentation inventory is on allocation for public market. MDV presentation is available to order in private market. PFS presentation inventory is on allocation for public market. MDV presentation is available to order in private market.
Health Canada comments